On Oct. 20 — the very same day the Centers for Disease Control and Prevention’s (CDC) crooked vaccine advisory committee members voted to add COVID-19 shots to the Child and Adolescent Immunization Schedule — Indonesia’s Ministry of Health took a bold step in a different direction: It banned the sale and prescription of pediatric cough syrups and other liquid medications, at least temporarily.
The ministry linked the cough syrups to kidney injuries that recently killed almost 100 Indonesian children and nearly 70 children in The Gambia in West Africa, and it voiced the suspicion that those numbers could be the tip of a much larger iceberg. After the rash of West African deaths, the World Health Organization issued a medical product alert for four brands of cough syrup manufactured in India and imported into The Gambia through a U.S. company — warning of the products’ possibly global distribution and calling for the substandard products’ removal from circulation.
As it happens, the COVID-19 shots promoted by the CDC and the syrups prohibited by the Indonesian ministry have one glaring commonality — both contain the chemical polyethylene glycol (PEG). Several months before the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization to Pfizer and Moderna for their PEG-containing mRNA COVID-19 shots, Children’s Health Defense (CHD) put the FDA on notice about PEG’s life-threatening anaphylactic potential — and sure enough, anaphylaxis was among the very first adverse events reported.